Alimera Sciences Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: March 25th, 2022
Here are a few of the most interesting Alimera Sciences statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Alimera Sciences Facts
- Alimera Sciences Website: Official Website
- Year Alimera Sciences was Founded: 2003
- Alimera Sciences Headquarters: Alphretta, GA
- Alimera Sciences Founder(s): Dan Myers, Daniel White, Dave Holland and Mark Testerman
- Current Alimera Sciences Chief Executive: Rick Eiswirth
What is Alimera Sciences?
Alimera, founded in June 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. Alimera’s commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. (source)
Alimera Sciences Employee Count
Number of Alimera Sciences employees:
Last updated 2/1/20
Alimera Sciences Revenue Totals
Alimera Sciences annual revenue:
- 2019: $53.943 million
- 2018: $46.599 million
Alimera Sciences annual net income:
- 2019: $10.443 million net loss
- 2018: $16.382 million net loss
Please note that some of these numbers are easier to find than others. A few of these Alimera Sciences statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags: